Compare
ABOS · 1 ticker
Price
100 is the close on the leftSnapshot
best blue · worst red
ABOS
Acumen Pharmaceuticals Inc
0.22
+0.00 (0.46%)
Valuation
| Index | RUT |
|---|---|
| Market Cap | $15.81M |
| Enterprise Value | -36.48M |
| Income | -103.96M |
| Sales | 0.00M |
| Book / share | 0.48 |
| Cash / share | 1.09 |
| Dividend Gr. 3/5Y | - - |
| Employees | 61 |
| IPO | Jul 01, 2021 |
Ratios
| Price / book | 0.46 |
|---|---|
| Price / cash | 0.20 |
| Quick Ratio | 1.89 |
| Current Ratio | 1.89 |
| Debt / equity | 0.76 |
| Long-term debt / equity | 0.17 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -1.55 |
|---|---|
| Earnings next year | -0.75 |
| Earnings next quarter | -0.40 |
| Earnings this year | 23.15% |
| Earnings growth, 5 years | 50.45% |
| Past earnings growth | -23.82% -61.49% |
| Past sales growth | - - |
| Earnings vs last year | 29.92% |
| Earnings vs last quarter | 19.67% |
| Earnings | Oct 26 BMO · 18 days ago |
| Surprise | 9.93% - |
Ownership
| Insiders own | 14.60% |
|---|---|
| Insider trades | -0.37% |
| Institutions own | 59.01% |
| Institution trades | 3.46% |
| Return on assets | -91.28% |
| Return on equity | -162.72% |
| Return on capital | -256.84% |
| 20-day average | -79.70% |
| 50-day average | -88.17% |
| 200-day average | -90.91% |
Technical
| Shares out | 72.33M |
|---|---|
| Shares floating | 61.76M |
| Short / float | 7.38% |
| Short ratio | 1.82 |
| Short interest | 4.56M |
| 52-week high | 3.60 -93.9% |
| 52-week low | 0.19 +14.7% |
| Volatility | 7.95% 14.03% |
| Average range | 0.17 |
| Strength index | 21.49 |
| Market sensitivity | 0.45 |
| Relative volume | 0.05 |
| Avg Volume | 2.50M |
| Volume | 5,847 |
Performance
| Perf Week | -2.24% |
|---|---|
| Perf Month | -86.92% |
| Perf Quarter | -91.79% |
| Perf Half Y | -90.42% |
| Perf YTD | -89.64% |
| Perf Year | -87.93% |
| Perf 3Y | -89.24% |
| Perf 5Y | -98.31% |
| Recommendation | 3.20 |
| Target Price | 1.00 |
| Prev Close | 0.22 |
| Price | 0.22 |
| Change % | 0.23% |
Compare
| ABOS | |
|---|---|
| Price | 0.22 |
| Change | +0.00 (0.46%) |
Compare · Valuation
| ABOS | |
|---|---|
| Index | RUT |
| Market Cap | $15.81M |
| Enterprise Value | -36.48M |
| Income | -103.96M |
| Sales | 0.00M |
| Book / share | 0.48 |
| Cash / share | 1.09 |
| Dividend Gr. 3/5Y | - - |
| Employees | 61 |
| IPO | Jul 01, 2021 |
Compare · Ratios
| ABOS | |
|---|---|
| Price / book | 0.46 |
| Price / cash | 0.20 |
| Quick Ratio | 1.89 |
| Current Ratio | 1.89 |
| Debt / equity | 0.76 |
| Long-term debt / equity | 0.17 |
| Options and short | Yes / Yes |
Compare · Earnings
| ABOS | |
|---|---|
| Earnings / share | -1.55 |
| Earnings next year | -0.75 |
| Earnings next quarter | -0.40 |
| Earnings this year | 23.15% |
| Earnings growth, 5 years | 50.45% |
| Past earnings growth | -23.82% -61.49% |
| Past sales growth | - - |
| Earnings vs last year | 29.92% |
| Earnings vs last quarter | 19.67% |
| Earnings | Oct 26 BMO · 18 days ago |
| Surprise | 9.93% - |
Compare · Ownership
| ABOS | |
|---|---|
| Insiders own | 14.60% |
| Insider trades | -0.37% |
| Institutions own | 59.01% |
| Institution trades | 3.46% |
| Return on assets | -91.28% |
| Return on equity | -162.72% |
| Return on capital | -256.84% |
| 20-day average | -79.70% |
| 50-day average | -88.17% |
| 200-day average | -90.91% |
Compare · Technical
| ABOS | |
|---|---|
| Shares out | 72.33M |
| Shares floating | 61.76M |
| Short / float | 7.38% |
| Short ratio | 1.82 |
| Short interest | 4.56M |
| 52-week high | 3.60 -93.9% |
| 52-week low | 0.19 +14.7% |
| Volatility | 7.95% 14.03% |
| Average range | 0.17 |
| Strength index | 21.49 |
| Market sensitivity | 0.45 |
| Relative volume | 0.05 |
| Avg Volume | 2.50M |
| Volume | 5,847 |
Compare · Performance
| ABOS | |
|---|---|
| Perf Week | -2.24% |
| Perf Month | -86.92% |
| Perf Quarter | -91.79% |
| Perf Half Y | -90.42% |
| Perf YTD | -89.64% |
| Perf Year | -87.93% |
| Perf 3Y | -89.24% |
| Perf 5Y | -98.31% |
| Recommendation | 3.20 |
| Target Price | 1.00 |
| Prev Close | 0.22 |
| Price | 0.22 |
| Change % | 0.23% |